Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Safety Info. No. 267 Focuses on Reye Syndrome Due to Salicylate
July 9, 2001
- Yamanouchi Forms Alliance with Celera Genomics
July 9, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 9, 2001
- JPMA to Propose New Drug Benefit System: Mr Nagayama
July 9, 2001
- Non-member Countries' Interest in ICH to Be Surveyed
July 9, 2001
- Sysmex: POC Test Information System
July 9, 2001
- JMA Proposes New Medical Fee Payment System by Type of Medical Institution
July 9, 2001
- Tanabe to License DDS Technology to aaiPharma in the US
July 9, 2001
- Council Recommends that Profit-making Companies Operate Hospitals
July 9, 2001
- Medrad to Directly Market Image Diagnostic Systems
July 9, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
July 9, 2001
- JEOL: EIA-based Radical Analyzer
July 9, 2001
- BUSINESS NEWS IN BRIEF -3-
July 9, 2001
- CDFS Committee to Draft GL for Package Inserts for Medical Devices
July 9, 2001
- BUSINESS NEWS IN BRIEF -2-
July 9, 2001
- WORLD NEWS IN BRIEF
July 9, 2001
- BUSINESS NEWS IN BRIEF -1-
July 9, 2001
- Pharmacia Enhances R&D Organization in Japan
July 9, 2001
- Shareholders' Meetings Last Longer Due to Increasing Number of Questions
July 9, 2001
- Superiority of Singulaire over Pranlukast Verified: Banyu Symposium
July 9, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…